Elite Pharmaceuticals Inc investor relations material

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsules for cardiovascular diseases.